Tag: Ophthalmic infections

*Pseudomonas aeruginosa* is a formidable opportunistic pathogen, and resistance to fluoroquinolones, the only oral therapy for it, is increasingly prevalent [1.4.2, 1.4.3]. This raises a critical question for clinicians: **Does gatifloxacin cover pseudomonas** effectively in clinical settings?

Sulfacetamide is a sulfonamide antibiotic that works by inhibiting the bacterial synthesis of folic acid, a compound essential for bacterial growth. This mechanism makes it effective against a range of susceptible bacteria, primarily in treating superficial infections. Understanding what bacteria does sulfacetamide treat is crucial for its appropriate use in ophthalmic and dermatological conditions.

First isolated in 1947, Chloromycetin (generic name chloramphenicol) is a potent, broad-spectrum antibiotic that is now primarily reserved for serious and life-threatening infections when safer alternatives are ineffective or contraindicated. Its historical use has evolved significantly due to the discovery of serious adverse effects, which have limited its modern application.